Witzig, T. E., LaPlant, B., Habermann, T. M., McPhail, E., Inwards, D. J., Micallef, I. N., . . . Johnston, P. B. (2017). High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: Updated results from NCCTG N1085 (Alliance). Blood Cancer J.
Chicago Style aipamenaWitzig, T E., et al. "High Rate of Event-free Survival At 24 Months With Everolimus/RCHOP for Untreated Diffuse Large B-cell Lymphoma: Updated Results From NCCTG N1085 (Alliance)." Blood Cancer J 2017.
MLA aipamenaWitzig, T E., et al. "High Rate of Event-free Survival At 24 Months With Everolimus/RCHOP for Untreated Diffuse Large B-cell Lymphoma: Updated Results From NCCTG N1085 (Alliance)." Blood Cancer J 2017.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.